| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Kinase Fusion Gene:COMMD9_CDKL2 |
Kinase Fusion Protein Summary |
 Kinase Fusion gene summary |
| Kinase Fusion partner gene information | Kinase Fusion gene name: COMMD9_CDKL2 | KinaseFusionDB ID: KFG1400 | FusionGDB2.0 ID: KFG1400 | Hgene | Tgene | Gene symbol | COMMD9 | CDKL2 | Gene ID | 29099 | 8999 | |
| Gene name | COMM domain containing 9 | cyclin dependent kinase like 2 | ||||||||||
| Synonyms | C11orf55|HSPC166|LINC00610 | KKIAMRE|P56 | ||||||||||
| Cytomap | 11p13 | 4q21.1 | ||||||||||
| Type of gene | protein-coding | protein-coding | ||||||||||
| Description | COMM domain-containing protein 9 | cyclin-dependent kinase-like 2CDC2-related kinasep56 KKIAMRE protein kinaseprotein kinase p56 KKIAMREserine/threonine protein kinase KKIAMREtesticular tissue protein Li 35 | ||||||||||
| Modification date | 20240407 | 20240403 | ||||||||||
| UniProtAcc | Q9P000 | Q92772 | ||||||||||
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000263401, ENST00000452374, ENST00000532705, ENST00000533308, | ENST00000307465, ENST00000429927, | |||||||||
| Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: COMMD9 [Title/Abstract] AND CDKL2 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | COMMD9(36310912)-CDKL2(76507108), # samples:2 | |||||||||||
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Kinase Fusion gene breakpoints across COMMD9 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Kinase Fusion gene breakpoints across CDKL2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
| Kinase Fusion gene information. |
| Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
| ChimerDB4 | TCGA-BC-A10Z-01A | COMMD9 | chr11 | 36310912 | CDKL2 | chr4 | 76507108 |
Top |
Kinase Fusion ORF Analysis |
| Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:36310912/:76507108) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| COMMD9 | CDKL2 |
| FUNCTION: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits (PubMed:23637203). {ECO:0000269|PubMed:15799966, ECO:0000269|PubMed:23637203, ECO:0000305|PubMed:21778237}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
| - Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of COMMD9_CDKL2 |
| Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
| Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
| CDKL2 | Q92772 | human | MAP1S | Q66K74 | S900 | DrAsRPLsARsEPsE |
| Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
| Enriched GO biological processes of the phosphorylation target genes of the kinase |
| Kinase | GOID | GO term | P.adjust |
| CDKL2 | ID | Description | 0.00e+00 |
| CDKL2 | GO:0034454 | microtubule anchoring at centrosome | 8.18e-03 |
| CDKL2 | GO:0072393 | microtubule anchoring at microtubule organizing center | 8.18e-03 |
| CDKL2 | GO:0034453 | microtubule anchoring | 8.18e-03 |
| CDKL2 | GO:0034643 | establishment of mitochondrion localizatio | 1.38e-03 |
| CDKL2 | GO:0031114 | regulation of microtubule depolymerization | 8.18e-03 |
| CDKL2 | GO:0051654 | establishment of mitochondrion localization | 8.18e-03 |
| CDKL2 | GO:0007019 | microtubule depolymerization | 1.06e-02 |
| CDKL2 | GO:0051646 | mitochondrion localization | 1.06e-02 |
| CDKL2 | GO:1901879 | regulation of protein depolymerization | 1.28e-02 |
| CDKL2 | GO:0072384 | organelle transport along microtubule | 1.28e-02 |
| CDKL2 | GO:0031110 | regulation of microtubule polymerization or depolymerization | 1.28e-02 |
| CDKL2 | GO:0051310 | metaphase chromosome alignment | 1.28e-02 |
| CDKL2 | GO:0051303 | establishment of chromosome localization | 1.28e-02 |
| CDKL2 | GO:0051261 | protein depolymerization | 1.28e-02 |
| CDKL2 | GO:0050000 | chromosome localization | 1.28e-02 |
| CDKL2 | GO:0043244 | regulation of protein-containing complex disassembly | 1.28e-02 |
| CDKL2 | GO:0001578 | microtubule bundle formation | 1.28e-02 |
| CDKL2 | GO:0007052 | mitotic spindle organization | 1.28e-02 |
| CDKL2 | GO:0031109 | microtubule polymerization or depolymerization | 1.28e-02 |
| CDKL2 | GO:0070507 | regulation of microtubule cytoskeleton organization | 1.41e-02 |
| CDKL2 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 1.41e-02 |
| CDKL2 | GO:0010970 | transport along microtubule | 1.43e-02 |
| CDKL2 | GO:0007051 | spindle organization | 1.57e-02 |
| CDKL2 | GO:0030705 | cytoskeleton-dependent intracellular transport | 1.57e-02 |
| CDKL2 | GO:0099111 | microtubule-based transport | 1.57e-02 |
| CDKL2 | GO:0016358 | dendrite development | 1.65e-02 |
| CDKL2 | GO:0032984 | protein-containing complex disassembly | 1.67e-02 |
| CDKL2 | GO:0032886 | regulation of microtubule-based process | 1.70e-02 |
| CDKL2 | GO:0098813 | nuclear chromosome segregation | 1.98e-02 |
| CDKL2 | GO:1902903 | regulation of supramolecular fiber organization | 2.39e-02 |
| CDKL2 | GO:0007018 | microtubule-based movement | 2.45e-02 |
| CDKL2 | GO:0007059 | chromosome segregation | 2.45e-02 |
| CDKL2 | GO:0007409 | axonogenesis | 2.51e-02 |
| CDKL2 | GO:0051656 | establishment of organelle localization | 2.56e-02 |
| CDKL2 | GO:0022411 | cellular component disassembly | 2.63e-02 |
Top |
Related Drugs to COMMD9_CDKL2 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
| Distribution of the number of studies mentioning COMMD9-CDKL2 and kinase inhibitors the PubMed Abstract (04-01-2024) |
| Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to COMMD9_CDKL2 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
| MeSH ID | MeSH term |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
| Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
| Clinical Trials from clinicaltrials.gov (06-17-2024) |
| Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |
Copyright 2024-Present -The University of Texas Health Science Center at Houston
Web File Viewing | Emergency Information |Campus Carry|Site Policies |